PEMF Therapy Reduces Bone Loss During Limb Lengthening: A Study on Pediatric Patients

PEMF Therapy Reduces Bone Loss During Limb Lengthening: A Study on Pediatric Patients

Read the paper here.

Limb lengthening procedures, often used to correct discrepancies in leg length due to congenital or developmental issues, can lead to a serious side effect—bone loss (osteoporosis) in the segments surrounding the surgical site. But a study from the University of Sheffield suggests that Pulsed Electromagnetic Field (PEMF) therapy may help mitigate this complication.


Study Overview

  • Participants: 13 children and adolescents (ages 9–19) undergoing lower limb lengthening

  • Procedure: Lengthening of femurs or tibias using external fixators (Orthofix, Ilizarov, Sequoia)

  • Groups: Patients were randomly assigned to receive either an active PEMF coil or a sham (inactive) coil

  • PEMF Protocol: 4 hours daily of PEMF exposure during the distraction phase of limb lengthening

Bone mineral density (BMD) was measured at three key locations—within the lengthened area (distraction gap), and in the bone segments proximal (above) and distal (below) the surgical site—using dual-energy X-ray absorptiometry (DXA).


Key Findings

PEMF Prevents Bone Loss Below the Surgical Site

  • In the inactive (sham) group, bone density in the distal segment dropped significantly—up to 46% by 12 months after surgery.

  • In contrast, the PEMF-treated group experienced only a 13% loss in the same period—a powerful protective effect.

No Effect on Bone Formation in the Lengthened Area

  • Both groups formed new bone in the distraction gap at similar rates.

  • This suggests PEMF’s primary benefit here is preservation, not acceleration of bone formation.

Mild Bone Density Gains Above the Surgical Site

  • Patients using PEMF showed slight improvements in bone density in the proximal bone segment—possibly linked to localized healing responses.


Why This Matters

Post-surgical bone loss can increase the risk of future fractures, especially in growing children. The study highlights PEMF therapy’s potential to:

  • Protect vulnerable bone segments during orthopedic lengthening procedures

  • Reduce the long-term risks of regional disuse osteoporosis

  • Serve as a safe, non-invasive adjunct to improve outcomes in pediatric orthopedic care


Conclusion

While PEMF didn’t speed up new bone formation at the surgical site, it significantly protected surrounding bone from density loss, a critical factor in recovery and long-term bone health. This study adds to the growing body of evidence supporting PEMF’s role in orthopedic healing and bone preservation—especially in children undergoing complex procedures like limb lengthening.